Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/335864
Share/Export:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invite to open peer review
Title

5-(tryptophylamino)-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based cholecystokinin receptor antagonists: Reversal of CCK1 receptor subtype selectivity toward CCK2 receptors

AuthorsMuñoz, Pilar; García-López, M. Teresa CSIC ; Cenarruzabeitia, Edurne CSIC; Río, Joaquín del CSIC; Dufresne, Marlene; Foucaud, Magali; Fourmy, Daniel; Herranz, Rosario CSIC ORCID
KeywordsAntagonists
Pyrimidine
Reaction products
Receptors,Selectivity
Issue Date4-Sep-2004
PublisherAmerican Chemical Society
CitationJournal of Medicinal Chemistry 47(21): 5318-5329 (2004)
AbstractWith the aim of reversing selectivity or antagonist/agonist functionality in the 5-(tryptophylamino)-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-derived potent and highly selective CCK1 antagonists, a series of 4-benzyl and 4-methyl derivatives have been synthesized. Whereas the introduction of the benzyl group led, in all cases, to complete loss of the binding affinity, the incorporation of the methyl group gave a different result depending on the stereochemistry of the 1,3-dioxoperhydropyrido[1,2-c]pyrimidine scaffold. Thus, the introduction of the methyl group into the (4aS,5R)-diastereoisomers, giving a (4S)-configuration, produced a 3-fold increase in the CCK1 binding potency and selectivity. However, the same structural manipulation in the opposite (4aR,5S)-stereochemistry, leading to a (4R,4aR,5S)-configuration, produced reversal of the selectivity for CCK1 to the CCK2 receptors. The replacement of the Boc group at the tryptophan moiety by a 2-adamantyloxycarbonyl group also contributed to that reversal. The resulting compounds displayed moderate CCK2 antagonist activity in rat and human receptors, and a very small partial agonist effect on the production of inositol phosphate in COS-7 cells transfected with the wild-type human CCK2 receptor.
Publisher version (URL)http://dx.doi.org/10.1021/jm0498755
URIhttp://hdl.handle.net/10261/335864
DOI10.1021/jm0498755
ISSN0022-2623
Appears in Collections:(IQM) Artículos




Files in This Item:
File Description SizeFormat
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record

CORE Recommender

SCOPUSTM   
Citations

8
checked on May 21, 2024

WEB OF SCIENCETM
Citations

6
checked on Feb 25, 2024

Page view(s)

10
checked on May 27, 2024

Download(s)

3
checked on May 27, 2024

Google ScholarTM

Check

Altmetric

Altmetric


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.